| Literature DB >> 32442405 |
Michael Orthofer1, Armand Valsesia2, Reedik Mägi3, Qiao-Ping Wang4, Joanna Kaczanowska5, Ivona Kozieradzki1, Alexandra Leopoldi1, Domagoj Cikes1, Lydia M Zopf6, Evgenii O Tretiakov7, Egon Demetz8, Richard Hilbe8, Anna Boehm8, Melita Ticevic1, Margit Nõukas3, Alexander Jais9, Katrin Spirk10, Teleri Clark11, Sabine Amann9, Maarja Lepamets3, Christoph Neumayr5, Cosmas Arnold5, Zhengchao Dou12, Volker Kuhn8, Maria Novatchkova5, Shane J F Cronin1, Uwe J F Tietge13, Simone Müller14, J Andrew Pospisilik15, Vanja Nagy16, Chi-Chung Hui12, Jelena Lazovic6, Harald Esterbauer9, Astrid Hagelkruys1, Ivan Tancevski8, Florian W Kiefer10, Tibor Harkany17, Wulf Haubensak5, G Gregory Neely11, Andres Metspalu3, Jorg Hager18, Nele Gheldof19, Josef M Penninger20.
Abstract
There is considerable inter-individual variability in susceptibility to weight gain despite an equally obesogenic environment in large parts of the world. Whereas many studies have focused on identifying the genetic susceptibility to obesity, we performed a GWAS on metabolically healthy thin individuals (lowest 6th percentile of the population-wide BMI spectrum) in a uniquely phenotyped Estonian cohort. We discovered anaplastic lymphoma kinase (ALK) as a candidate thinness gene. In Drosophila, RNAi mediated knockdown of Alk led to decreased triglyceride levels. In mice, genetic deletion of Alk resulted in thin animals with marked resistance to diet- and leptin-mutation-induced obesity. Mechanistically, we found that ALK expression in hypothalamic neurons controls energy expenditure via sympathetic control of adipose tissue lipolysis. Our genetic and mechanistic experiments identify ALK as a thinness gene, which is involved in the resistance to weight gain.Entities:
Keywords: GWAS; anaplastic lymphoma kinase; energy expenditure; hypothalamus; lipolysis; norepinephrine; thinness
Mesh:
Substances:
Year: 2020 PMID: 32442405 DOI: 10.1016/j.cell.2020.04.034
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582